Companies
From start-ups to market leaders, access critical company intelligence on a global scale
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
Inflammatory Bowel Disease Market Report
Learn about the digital activities being undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease (CD) and ulcerative colitis (UC).
This Inflammatory Bowel Disease market report looks at the various digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe CD and UC, and takes a deep dive into the digital activities that are aimed at patients and/or HCPs.
Our Digital Landscape market report takes a look at branded websites, social media, mobile apps and more. Based on an analysis conducted by a combination of GlobalData’s digital and disease-specific teams, our report also analyzes data such as website traffic, SEO and social media interaction.
Key highlights include:
US patients: Abbvie offers the strongest support for IBD patients, particular branded, unbranded and mobile app. There is opportunity for a well-integrated campaign to support patients.
US HCPs: Good support available in IBD branded space. Unbranded and mobile app landscapes are sparse.
EUCAN patients: Good brand support for patients in Germany, UK and Canada. Unbranded support is the strongest in Germany on the whole, with new sites launched by Janssen and Pfizer in 2017.
EUCAN HCPs: Underdeveloped landscape.